A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,365,272 shares of EW stock, worth $99.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,365,272
Previous 1,364,202 0.08%
Holding current value
$99.1 Million
Previous $126 Million 28.5%
% of portfolio
0.06%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$59.7 - $93.78 $63,879 - $100,344
1,070 Added 0.08%
1,365,272 $90.1 Million
Q2 2024

Jul 19, 2024

SELL
$84.3 - $94.31 $20.7 Million - $23.2 Million
-245,664 Reduced 15.26%
1,364,202 $126 Million
Q1 2024

Apr 19, 2024

BUY
$72.54 - $95.56 $476,080 - $627,160
6,563 Added 0.41%
1,609,866 $154 Million
Q4 2023

Jan 30, 2024

SELL
$61.71 - $77.76 $2.01 Million - $2.54 Million
-32,609 Reduced 1.99%
1,603,303 $122 Million
Q3 2023

Oct 30, 2023

BUY
$69.28 - $93.38 $2.58 Million - $3.48 Million
37,250 Added 2.33%
1,635,912 $113 Million
Q2 2023

Jul 31, 2023

SELL
$81.41 - $94.33 $20.8 Million - $24.1 Million
-254,997 Reduced 13.76%
1,598,662 $151 Million
Q1 2023

Apr 27, 2023

SELL
$74.26 - $84.51 $30.3 Million - $34.5 Million
-408,169 Reduced 18.05%
1,853,659 $153 Million
Q4 2022

Jan 30, 2023

SELL
$68.3 - $87.44 $14.8 Million - $18.9 Million
-216,272 Reduced 8.73%
2,261,828 $169 Million
Q3 2022

Oct 21, 2022

SELL
$82.37 - $107.29 $17.3 Million - $22.6 Million
-210,359 Reduced 7.82%
2,478,100 $205 Million
Q2 2022

Jul 26, 2022

BUY
$86.5 - $128.27 $17.4 Million - $25.7 Million
200,725 Added 8.07%
2,688,459 $256 Million
Q1 2022

Apr 27, 2022

SELL
$101.96 - $128.34 $51.4 Million - $64.7 Million
-503,756 Reduced 16.84%
2,487,734 $293 Million
Q4 2021

Feb 02, 2022

SELL
$106.37 - $130.68 $56.2 Million - $69.1 Million
-528,474 Reduced 15.01%
2,991,490 $388 Million
Q3 2021

Oct 25, 2021

SELL
$102.91 - $122.75 $21.8 Million - $26 Million
-211,707 Reduced 5.67%
3,519,964 $398 Million
Q2 2021

Aug 02, 2021

SELL
$83.84 - $104.76 $16.3 Million - $20.4 Million
-194,951 Reduced 4.96%
3,731,671 $386 Million
Q1 2021

Apr 30, 2021

BUY
$78.68 - $90.67 $14.6 Million - $16.8 Million
185,231 Added 4.95%
3,926,622 $328 Million
Q4 2020

Feb 05, 2021

BUY
$71.69 - $91.23 $6.72 Million - $8.55 Million
93,691 Added 2.57%
3,741,391 $341 Million
Q3 2020

Oct 30, 2020

BUY
$67.19 - $87.44 $9.52 Million - $12.4 Million
141,641 Added 4.04%
3,647,700 $291 Million
Q2 2020

Jul 27, 2020

BUY
$57.54 - $76.95 $138 Million - $184 Million
2,392,734 Added 214.92%
3,506,059 $242 Million
Q1 2020

Apr 27, 2020

BUY
$52.41 - $81.0 $11.8 Million - $18.3 Million
225,682 Added 25.42%
1,113,325 $210 Million
Q4 2019

Jan 31, 2020

BUY
$71.7 - $82.09 $216,534 - $247,911
3,020 Added 0.34%
887,643 $207 Million
Q3 2019

Oct 31, 2019

BUY
$61.55 - $75.43 $4.47 Million - $5.47 Million
72,545 Added 8.93%
884,623 $195 Million
Q2 2019

Jul 29, 2019

SELL
$55.74 - $64.41 $1.04 Million - $1.21 Million
-18,717 Reduced 2.25%
812,078 $150 Million
Q1 2019

May 08, 2019

BUY
$47.89 - $64.05 $590,148 - $789,288
12,323 Added 1.51%
830,795 $159 Million
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $6.43 Million - $7.89 Million
138,621 Added 20.39%
818,472 $123 Million
Q3 2018

Nov 07, 2018

BUY
$45.7 - $58.03 $860,393 - $1.09 Million
18,827 Added 2.85%
679,851 $118 Million
Q2 2018

Aug 01, 2018

BUY
$42.45 - $51.3 $1.62 Million - $1.96 Million
38,257 Added 6.14%
661,024 $96.2 Million
Q1 2018

May 01, 2018

BUY
$37.19 - $47.45 $759,866 - $969,498
20,432 Added 3.39%
622,767 $86.9 Million
Q4 2017

Feb 06, 2018

BUY
$33.79 - $39.39 $376,893 - $439,356
11,154 Added 1.89%
602,335 $67.9 Million
Q3 2017

Nov 07, 2017

SELL
$36.29 - $38.83 $336,916 - $360,497
-9,284 Reduced 1.55%
591,181 $64.6 Million
Q2 2017

Aug 07, 2017

BUY
N/A
600,465
600,465 $71 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.